Anna Mele

840 total citations
25 papers, 410 citations indexed

About

Anna Mele is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Anna Mele has authored 25 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 17 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in Anna Mele's work include Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (11 papers) and Cancer Treatment and Pharmacology (6 papers). Anna Mele is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Protein Degradation and Inhibitors (11 papers) and Cancer Treatment and Pharmacology (6 papers). Anna Mele collaborates with scholars based in Italy, United Kingdom and Brazil. Anna Mele's co-authors include Pietro Leoni, Massimo Offidani, H. G. Prentice, Laura Corvatta, C C Kibbler, Serena Rupoli, Marino Brunori, Mauro Montanari, Attilio Olivieri and Riccardo Centurioni and has published in prestigious journals such as Blood, Clinical Infectious Diseases and British Journal of Haematology.

In The Last Decade

Anna Mele

23 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Mele Italy	11	191	189	151	101	98	25	410
Toshimitsu Ueki Japan	10	128 0.7×	162 0.9×	220 1.5×	53 0.5×	33 0.3×	43	390
Yuju Ohno Japan	10	254 1.3×	121 0.6×	106 0.7×	29 0.3×	42 0.4×	34	381
Akihito Shinohara Japan	13	221 1.2×	104 0.6×	176 1.2×	15 0.1×	65 0.7×	43	493
Jane Burgess Australia	14	102 0.5×	239 1.3×	344 2.3×	31 0.3×	113 1.2×	21	670
Xuying Pei China	11	138 0.7×	117 0.6×	178 1.2×	33 0.3×	22 0.2×	26	330
Stef Meers Belgium	9	103 0.5×	61 0.3×	218 1.4×	52 0.5×	33 0.3×	22	416
Petra Keslová Czechia	11	91 0.5×	81 0.4×	112 0.7×	18 0.2×	61 0.6×	24	377
Olle Ringd n Sweden	8	183 1.0×	68 0.4×	148 1.0×	20 0.2×	13 0.1×	8	320
Ann‐Marie Lobo United States	9	37 0.2×	86 0.5×	129 0.9×	25 0.2×	74 0.8×	23	526
Giorgia Battipaglia France	13	376 2.0×	117 0.6×	49 0.3×	20 0.2×	47 0.5×	23	460

Countries citing papers authored by Anna Mele

Since Specialization

Citations

This map shows the geographic impact of Anna Mele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mele more than expected).

Fields of papers citing papers by Anna Mele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Mele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mele. The network helps show where Anna Mele may publish in the future.

Co-authorship network of co-authors of Anna Mele

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Mele. A scholar is included among the top collaborators of Anna Mele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Mele. Anna Mele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaudio, Francesco, Anna Mele, Nicola Di Renzo, et al.. (2024). Plerixafor in association with R-DHAP and G-CSF to mobilize a large number of CD34 + cells in patients with relapsed-refractory diffuse large B-cell lymphomas. Annals of Hematology. 103(12). 5799–5805. 1 indexed citations

Mele, Giuseppe, Nicola Cascavilla, Nicola Di Renzo, et al.. (2022). Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’. Annals of Hematology. 101(8). 1727–1739.

Gaudio, Francesco, Patrizio Mazza, Anna Mele, et al.. (2019). Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin’s lymphoma patients. Annals of Hematology. 98(6). 1449–1455. 4 indexed citations

Pavone, Vincenzo, Anna Mele, Giorgina Specchia, et al.. (2018). Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP). Annals of Hematology. 97(10). 1817–1824. 6 indexed citations

Gaudio, Francesco, Patrizio Mazza, Angelo Michele Carella, et al.. (2018). Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP). Clinical Lymphoma Myeloma & Leukemia. 19(1). 35–40. 5 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leukemia & lymphoma. 52(5). 776–785. 17 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed–refractory multiple myeloma. Annals of Hematology. 90(12). 1449–1456. 14 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2008). Thalidomide‐dexamethasone versus Interferon‐alpha‐dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study. British Journal of Haematology. 144(5). 653–659. 23 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2008). Serum C-Reactive Protein at Diagnosis and Response to Therapy Is the Most Powerful Factor Predicting Outcome of Multiple Myeloma Treated with Thalidomide/Anthracycline—Based Therapy. Clinical Lymphoma & Myeloma. 8(5). 294–299. 9 indexed citations

10.

Mele, Anna, Massimo Offidani, Giuseppe Visani, et al.. (2007). Technetium‐99m sestamibi scintigraphy is sensitive and specific for the staging and the follow‐up of patients with multiple myeloma: a multicentre study on 397 scans. British Journal of Haematology. 136(5). 729–735. 25 indexed citations

11.

Offidani, Massimo, Claudia Polloni, Laura Corvatta, et al.. (2007). ThaDD-V Treatment for Patients with Relapsed/Refractory Multiple Myeloma: A Feasibility/Activity Study.. Blood. 110(11). 2729–2729. 1 indexed citations

12.

Malerba, Lara, et al.. (2006). Pegfilgrastim effectively mobilizes PBSC in a poor mobilizer multiple myeloma patient. European Journal Of Haematology. 76(5). 436–439. 10 indexed citations

13.

Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (2004). Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma. The Hematology Journal. 5(4). 312–317. 21 indexed citations

14.

Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Common and rare side‐effects of low‐dose thalidomide in multiple myeloma: focus on the dose‐minimizing peripheral neuropathy. European Journal Of Haematology. 72(6). 403–409. 34 indexed citations

15.

Offidani, Massimo, Laura Corvatta, Riccardo Centurioni, et al.. (2003). High-dose daunorubicin as liposomal compound (Daunoxome®) in elderly patients with acute lymphoblastic leukemia1. The Hematology Journal. 4(1). 47–53. 18 indexed citations

16.

Mele, Anna, et al.. (2002). Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplantation. 29(8). 691–698. 112 indexed citations

17.

Offidani, Massimo, Anna Mele, Laura Corvatta, et al.. (2002). Gemcitabine Alone or Combined with Cisplatin in Relapsed or Refractory Multiple Myeloma. Leukemia & lymphoma. 43(6). 1273–1280. 10 indexed citations

18.

Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (2001). A Predictive Model of Varicella-Zoster Virus Infection after Autologous Peripheral Blood Progenitor Cell Transplantation. Clinical Infectious Diseases. 32(10). 1414–1422. 32 indexed citations

19.

Pulsoni, Alessandro, Livio Pagano, Maria Elena Tosti, et al.. (2000). Retrospective survival analysis of elderly patients with acute myeloid leukemia (AML) treated with aggressive or non aggressive therapy. 2 indexed citations

20.

Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (1999). Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplantation. 24(10). 1079–1087. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact